17 Recruiting Ulcerative Colitis Phase 3 Clinical Trials
Active phase 3 studies for ulcerative colitis enrolling across the USA. Verify eligibility and contact site coordinators.
All Ulcerative Colitis studiesPhase 3 Studies for Ulcerative Colitis
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
📍 Digestive Health Specialists ( Site 0135) — Dothan, Alabama
View Study & Checklist ➔Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
📍 Digestive Health Specialists Of The Southeast — Dothan, Alabama
View Study & Checklist ➔A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔ABTECT - Maintenance
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
View Study & Checklist ➔A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
📍 Gastro Health Research - St. Vincent'S East /ID# 275089 — Birmingham, Alabama
View Study & Checklist ➔A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Om Research LLC — Lancaster, California
View Study & Checklist ➔Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
📍 Phoenix Children's Hospital /ID# 250135 — Phoenix, Arizona
View Study & Checklist ➔An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
📍 Center for Digestive Health (Colonoscopy Location) — Dothan, Alabama
View Study & Checklist ➔Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Onyx Clinical Research - Site Number: 8400021 — Peoria, Arizona
View Study & Checklist ➔A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
📍 Phoenix Children's Hospital — Phoenix, Arizona
View Study & Checklist ➔A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
📍 Phoenix Childrens Hospital — Phoenix, Arizona
View Study & Checklist ➔A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
📍 UCSF Medical Center at Mission Bay — San Francisco, California
View Study & Checklist ➔A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
📍 Phoenix Children's Hospital /ID# 273015 — Phoenix, Arizona
View Study & Checklist ➔Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
📍 Digestive Health Specialists — Dothan, Alabama
View Study & Checklist ➔A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
📍 Del Sol Research Management, LLC - Site Number: 8400012 — Tucson, Arizona
View Study & Checklist ➔A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
📍 University of South Alabama (USA) Physicians Group — Mobile, Alabama
View Study & Checklist ➔